[Commentary on] Surveillance for recurrent bladder cancer using a point-of-care proteomic assay Grossman HB, Soloway M, Messing E, Katz G, Stein B, Kassabian V, Shen Y, Department of Urology, M.D. Anderson Cancer Center, Houston, TX.

Detalles Bibliográficos
Publicado en:Urologic Oncology Vol. 24; no. 3; pp. 274 - 276
Autor principal: See WA
Formato: abstract commentary Journal Article
Publicado: Elsevier B.V. May2006
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106469793&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106469793
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10781439
        JJ4
      jtl: Urologic Oncology
      issn: 10781439
      maglogo: N
    pubinfo:
      dt: May2006
      vid: 24
      iid: 3
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        106469793
        106469793
        2009208651
        10.1016/j.urolonc.2006.02.012
        106469793
      ppf: 274
      ppct: 2
      formats:
      tig:
        atl: [Commentary on] Surveillance for recurrent bladder cancer using a point-of-care proteomic assay Grossman HB, Soloway M, Messing E, Katz G, Stein B, Kassabian V, Shen Y, Department of Urology, M.D. Anderson Cancer Center, Houston, TX.
      aug:
        au: See WA
      sug:
        subj:
          Bladder Neoplasms Complications
          Recurrence Evaluation
          Confidence Intervals
          Cross Sectional Studies
          Sensitivity and Specificity
          United States
      pubtype: Academic Journal
      doctype:
        abstract
        commentary
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N